Board of Directors

The Board of Directors oversees the day-to-day running of our association and the Chairman of the Board is the highest representative of Asebio. The assembly held in December 2019 chose the candidacy with Ana Polanco (Merck) as chairwoman and Belén Barreiro (Ingenasa), Elena Rivas (A4Cell) y Javier Terriente (Zeclinics) as the three vice presidents. They will hold these offices until late 2023.

Imagen Ana Polanco - Presidenta de AseBio III

Merck

Chairwoman

Ana Polanco

Director of Market Access and Corporate Affairs at Merck since 2015. She is also a member of FEI (Forum of Innovative Companies), of the Board of Directors of the Digital Health Association and Dr. of the Executive Committee of CLOSINGAP.

Ingenasa

1st Vice President

Belén Barreiro

General Director at Ingenasa, a company specializing in biotechnology for the veterinary sector, which she joined in 1994 as marketing director.

Arrays For Cell Nanodevices

2sd Vice President

Elena Rivas

CEO at Arrays for Cell Nanodevices, SL

ZeClinics

3rd Vice President

Javier Terriente

CSO at Zeclinics

3P Biopharmaceuticals

Member of the Board

Dámaso Molero

General Director at 3P Biopharmaceuticals since 2007, Dámaso Molero has a long experience in pharmaceutical production, with more than 10 years as a plant manager in Shionogi

AbbVie

Member of the Board

Antonio Bañares

Director of Market Access and Governance at AbbVie since 2013. He had been previously Director of Health Management and Institutional Relations at Abbott Laboratories and General Director of the company's foundation.

Ability Pharmaceuticals

Member of the Board

Carles Domenech

CEO and Vice President of Business Development and Licensing at Ability Pharma since 2009. At the same time, he has been a consultant for biotech projects of the investment company Kieretsu Forum Spain.

ADL BIOPHARMA

Vocal

Ignacio Urbelz

Ignacio Urbelz es el director general de la compañía

Algaenergy

Member of the Board

Augusto Rodríguez Villa

President and CEO of AlgaEnergy, a company designed to create products derived from microalgae. He leads R+D+i projects in microalgae biotechnology.

Amadix

Member of the Board

Rocío Arroyo

CEO at Advanced Maker Discovery

Amgen

Vocal

Fina Lladós

Directora General de la biotecnológica Amgen para España y Portugal desde septiembre de 2017 y miembro del comité de dirección de la compañía desde 2009

Atrys Health

Member of the Board

Santiago de Torres

Executive Chairman of the Board at Atrys Health. Torres, a physician specializing in Clinical Pharmacology, is also part of the board of various organizations with social purposes.

Bayer Hispania S.L

Member of the Board

Richard Borreani

Director of Agricultural Policies and Institutional Relations at Bayer Crop Science Iberia, the agro division of the multinational, which is the third largest company in the world in products for agriculture.